Vaccines for Adults FY26-27

Solicitation / RFP / RFQ

This solicitation seeks proposals for one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for the purchase of standard commercial adult vaccines. The Centers for Disease Control and Prevention (CDC) intends to utilize these contracts to procure vaccines at prices below commercial market rates, supporting adult immunization programs funded by Section 317 vaccine purchase funds. Awardees will supply vaccines to state and local health departments and other authorized immunization programs.

• Supplies: A variety of adult vaccines are listed, including Hepatitis A, Hepatitis B, Herpes Zoster, HPV, E-IPV, MMR, Meningococcal, MPOX, RSV, Pneumococcal, Tetanus/Diphtheria, and Varicella vaccines.

• Quantity: Maximum quantities are specified per vaccine type, with minimum order sizes of 100 doses (10 for Varicella).

• Shelf Life: Vaccines must have a minimum of 12 months shelf life remaining upon delivery.

• Delivery: Delivery is required within 15 working days after receipt of order to CDC centralized distribution locations (Olive Branch, MS and Clermont, KY).

• Packaging: Must maintain FDA recommended temperatures during transit; electronic temperature monitoring is required.

• Licensure: Vaccines must be manufactured under current FDA establishment and product licenses.

• System Interface: Contractors must be able to interface with the CDC's Vaccine Tracking System (VTrckS) for order placement.

• Drug Supply Chain Security Act (DSCSA): Shipments must comply with DSCSA requirements, including Transaction Information, History, and Statement.

• Contract Type: Firm-Fixed-Price Indefinite Delivery/Indefinite Quantity (ID/IQ).

• Period of Performance: Contract period is 12 months from the date of award.

• Maximum Contract Value: Combined maximum value for all contracts is $906,765,181.88.

• Pricing: Contract unit prices shall not exceed the manufacturer's current Federal Ceiling Price (FCP). Federal Excise Tax (FET) may be included in negotiated prices.

• Submission Deadline: Offers are due by 1:00 PM EST on April 7, 2026.

• Submission Method: Offers must be submitted electronically via email to James Sprigler and Chad Turner.

• Evaluation Factors: Offers will be evaluated on Technical Proposal, Price Proposal, and Past Performance, all considered equal in importance. The government intends to make awards to all qualifying offerors.

• Offerors must be FDA-approved/authorized vaccine manufacturers or distributors.

• Specific subcontracting goals are outlined for small businesses.

• Attachment D-1 designates the CDC as an Authorized Distributor of Record (ADR).

• Offerors must propose FDA-approved vaccines and meet Federal Ceiling Price and Federal Excise Tax Credit provisions.

Form / Attachment / Pricing Sheet

This document, "Attachment 2 - List of Products," serves as a list of specific products required for the opportunity. Bidders should use this list to identify and potentially price the items needed.

• Item Number
• Product/Brand Name (listed as 'Vaccine')
• National Drug Code (NDC) (provided as a placeholder 'xxxxx-xxxx-xx')

This attachment is crucial for bidders to understand the specific products the government intends to procure. It will likely be used in conjunction with pricing sheets or proposal submissions to ensure that the correct items are being offered and priced accordingly.

Solicitation / RFP / RFQ

This document is a Solicitation/Contract/Order for Commercial Items, specifically a Request for Proposal (RFP) issued by the Centers for Disease Control and Prevention (CDC). It outlines the government's need for items or services as detailed in the "Schedule of Supplies/Services" (Block 20).

• The specific items or services to be procured are detailed in "See Schedule" for Blocks 11, 15, and 20.

• The solicitation is for an "Unrestricted" acquisition.

• Solicitation Issue Date: 03/24/2026

• Offer Due Date/Local Time: 04/07/2026, 1:00 PM EDT

• Award/Effective Date: 07/01/2026

• The document references FAR clauses 52.212-1, 52.212-3, and 52.212-5, which are incorporated by reference.

• Offerors must complete Blocks 12, 17, 23, 24, and 30.

• Invoices are to be submitted to the address in Block 18a unless otherwise noted.

• The solicitation is administered by the CDC Office of Acquisition Services.

• This acquisition is "Unrestricted."

• NAICS Code: 325412

• Size Standard: Not specified on this page, but the "Small Business" checkboxes are not selected.

• The document is Standard Form 1449 (Rev. 2/2012).

• Payment will be made by the CDC Office of Financial Resources.

• The document is 34 pages long, with this being page 1 of 34.

Form / Attachment / Pricing Sheet

This document is an Authorized Distributor of Record (ADR) Agreement between a Manufacturer/Supplier and the Centers for Disease Control and Prevention (CDC). It designates the CDC as an ADR in accordance with the Prescription Drug Marketing Act (PDMA) of 1988 and federal regulations (21 CFR Part 203).

• Agreement Validity: From dual execution until terminated by either party with 90 days' written notice.
• Scope: Establishes the CDC as an ADR. It does not alter other existing or future distribution agreements and confers no rights beyond ADR designation.
• Compliance: CDC agrees to comply with all applicable state and federal laws.
• Product Listing: Requires an attachment listing specific products CDC is authorized to distribute, or a statement that CDC is an ADR for the manufacturer's entire product line. Products should be identified by name, dosage form, strength, and NDC number.
• Options: Bidders must check if the distributor is the ADR for the entire product line or for products listed on an attachment (Attachment D-2).

Bidders need to understand if this ADR agreement is a prerequisite or a component of the overall opportunity. If the opportunity involves the distribution of pharmaceuticals or vaccines, this agreement outlines the terms under which the CDC can act as an authorized distributor. Bidders may need to ensure their proposed products or distribution plans align with this ADR designation or provide the necessary product listing if they are the Manufacturer/Supplier.